chronic autoimmune disease treatment
7% Boost Reveals Chronic Disease Management Overrated
Look, the 7% functional-mobility boost seen in neuromyelitis optica patients proves chronic disease management can deliver measurable health gains, not just marketing hype. 22% fewer hospital readmissions were recorded in a 2023 health-economics report for patients on the new Rockefeller protocol, showing the economic punch of targeted therapy. Medical Disclaimer: